Literature DB >> 14512889

Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions.

Chih-Te Wu1, Jason P Eiserich, Aftab A Ansari, Ross L Coppel, Sripriya Balasubramanian, Christopher L Bowlus, M Eric Gershwin, Judy Van De Water.   

Abstract

Previous studies have suggested that increased nitric oxide (NO)-mediated products are found in the livers of subjects with primary biliary cirrhosis (PBC), but the mechanisms involved remain enigmatic. We took advantage of immunohistochemistry and several unique monoclonal antibodies to study inflammatory cells responsible for the generation of NO, the enzymes responsible for NO production, the expression of 3-nitrotyrosine, and the presence of CD68(+) and/or myeloperoxidase (MPO)(+) cells. We examined a total of 113 liver specimens, including 64 with PBC, 19 with primary sclerosing cholangitis (PSC), 6 with non-A, non-B hepatitis, 6 with alcoholic liver disease, 4 with cryptogenic cirrhosis, 4 with biliary atresia, and 10 normal subjects. Twenty-two percent of PBC had elevated expression of 3-nitrotyrosine in their bile duct epithelial cells (BECs) (P =.0316). Furthermore, the BECs in PBC also demonstrated apoptotic changes. MPO-positive inflammatory cells were also noted adjacent to the basement membrane. In contrast, the liver of normal subjects showed few apoptotic changes in the bile ducts, with no evidence of MPO staining in the portal area. Furthermore, sections from livers of subjects with stage I or stage II PBC demonstrated significantly increased inflammatory cell infiltration (P =.0064) and elevated 3-nitrotyrosine expression in BECs (P =.0246) compared with stage III and IV. The presence of 3-nitrotyrosine was closely associated with infiltrating CD68- and/or MPO-positive cells. There was also a stage-associated difference in the presence of bile duct infiltrating cells and 3-nitrotyrosine in PBC with an increase dominant in early stage disease. In conclusion, NO and reactive oxygen species, collectively determined as 3-nitrotyrosine, are associated with bile duct destruction in PBC and are particularly prevalent in early stage disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512889     DOI: 10.1053/jhep.2003.50407

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  16 in total

Review 1.  Concept on the pathogenesis and treatment of primary biliary cirrhosis.

Authors:  Vasiliy-Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

2.  The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.

Authors:  Y M Ambrosini; G-X Yang; W Zhang; M Tsuda; S Shu; K Tsuneyama; P S C Leung; A A Ansari; R L Coppel; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

3.  Oxidative stress and antioxidant status in patients with autoimmune liver diseases.

Authors:  Eleanna T Kaffe; Eirini I Rigopoulou; George K Koukoulis; George N Dalekos; Anargyros N Moulas
Journal:  Redox Rep       Date:  2014-08-13       Impact factor: 4.412

4.  Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia.

Authors:  Cara L Mack; Rebecca M Tucker; Ronald J Sokol; Brian L Kotzin
Journal:  Clin Immunol       Date:  2005-05       Impact factor: 3.969

5.  Cutting edge issues in primary sclerosing cholangitis.

Authors:  Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

6.  Effects of modulating M3 muscarinic receptor activity on azoxymethane-induced liver injury in mice.

Authors:  Sandeep Khurana; Ravirajsinh Jadeja; William Twaddell; Kunrong Cheng; Vikrant Rachakonda; Neeraj Saxena; Jean-Pierre Raufman
Journal:  Biochem Pharmacol       Date:  2013-05-21       Impact factor: 5.858

7.  Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.

Authors:  K Wakabayashi; K Yoshida; P S C Leung; Y Moritoki; G-X Yang; K Tsuneyama; Z-X Lian; T Hibi; A A Ansari; L S Wicker; W M Ridgway; R L Coppel; I R Mackay; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2008-12-15       Impact factor: 4.330

8.  Increased plasma myeloperoxidase levels in systemic lupus erythematosus.

Authors:  Rosa Weiss Telles; Gilda Aparecida Ferreira; Neusa Pereira da Silva; Emilia Inoue Sato
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

9.  Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis.

Authors:  Patrick S C Leung; Lorenzo Rossaro; Paul A Davis; Ogyi Park; Atsushi Tanaka; Kentaro Kikuchi; Hiroshi Miyakawa; Gary L Norman; William Lee; M Eric Gershwin
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

Review 10.  Pathogenic role of oxidative and nitrosative stress in primary biliary cirrhosis.

Authors:  Ignazio Grattagliano; Giuseppe Calamita; Tiziana Cocco; David Q-H Wang; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.